Condensed Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2026	Mar. 31, 2025
Revenues		$ 336,595	$ 329,308
Cost of goods sold		260,286	264,959
Gross profit		76,309	64,349
Selling, general, and administrative expenses		58,634	51,344
Operating income		17,675	13,005
Other expenses (income):
Interest expense		154	170
Other expense (income), net		(772)	(271)
Total other expenses (income)		(618)	(101)
Income before income taxes		18,293	13,106
Provision for income taxes		4,749	3,833
Net income		13,544	9,273
Less net income (loss) attributable to non-controlling interests		249	(175)
Net income attributable to Guardian Pharmacy Services, Inc.		$ 13,295	$ 9,448
Class A and Class B common stock [Member]
Net income per share of Class A and Class B common stock
Basic	[1]	$ 0.21	$ 0.15
Diluted	[1]	$ 0.21	$ 0.15
Weighted-average Class A and Class B common shares outstanding
Basic		63,321	62,043
Diluted		63,692	62,914

[1] See Note 6 Basic and Diluted Net Income Per Share for the number of shares used in the computation of net income per share of Class A and Class B common stock and the basis for the computation of net income per share.